1-3 of 3
E. Bolotin, MD
Close
Sort by
Journal Articles

Long Term Survival after ASCT for AML: Multivariate Analysis Shows Adverse Effect of Collecting and Infusing Larger Numbers of CD 34 Positive Cells.

Clarence B. Sarkodee-Adoo, MD, FACP, Anthony S. Stein, MD, Margaret R. O’Donnell, MD, Ravi M. Bhatia, MD, E. Bolotin, MD, K. P. Chang, MD, Mark Kirschbaum, MD, Neil Kogut, MD, Auayporn Nademanee, MD, Pablo Parker, MD, Vinod Pullarkat, MD, David Snyder, MD, Ricardo Spielberger, MD, Marilyn L. Slovak, MD, Joseph Alvarnas, MD, Joy Fridey, MD, Jeffrey Schriber, MD, Eileen Smith, MD, Andy Dagis, J. Land, J. Palmer, N. Vora, Stephen Forman, MD FACP
Journal: Blood
Blood (2005) 106 (11): 2921.
https://doi.org/10.1182/blood.V106.11.2921.2921
Published: 2005
Journal Articles

Analysis of Long Term Outcome in Autologous Stem Cell Transplant (ASCT) for Acute Myelogenous Leukemia (AML) in First Remission (CR1) - a 15 Year Experience.

Anthony Selwyn Stein, MD, M. O’Donnell, MD, P. Parker, MD, R. Spielberger, MD, A. Nademanee, MD, R. Bhatia, MD, D. S. Snyder, MD, M. Kirschbaum, MD, V. Pullarkat, MD, N. Kogut, MD, E. Bolotin, MD, K. Chang, MD, C. Sarkodee-Adoo, MD, M. Slovak, MD, N. Vora, MD, J. Land, RN, A. Dagis, J. Palmer, S. J. Forman, MD
Journal: Blood
Blood (2004) 104 (11): 1870.
https://doi.org/10.1182/blood.V104.11.1870.1870
Published: 2004
Journal Articles

Peripheral Blood Stem Cells vs Bone Marrow for Matched Sibling Transplant in AML and ALL in First Remission.

Mark Kirschbaum, MD, M. O’Donnell, MD, R. Spielberger, MD, R. Bhatia, MD, V. Pullarkat, MD, A. S. Stein, MD, N. Kogut, MD, E. Bolotin, MD, K. Chang, MD, J. Land, RN, C. Sarkodee-Adoo, MD, D. Snyder, MD, S. J. Forman, MD.
Journal: Blood
Blood (2004) 104 (11): 3321.
https://doi.org/10.1182/blood.V104.11.3321.3321
Published: 2004